During bone cancer metastasis, RANKL plays an important role in the activation of osteoclastic bone resorption38, 39, and the anti-RANKL therapy for treatment and prevention of bone cancer metastasis is currently under development40. The gene discussed is TNFSF11; the disease is bone neoplasm.